Jinglin Xia

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Diffuse Large B Cell Lymphoma

Top Venues

Cell death & disease

Cardiovascular and interventional radiology

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas

This page only lists publications with an associated author ORCID identifier.

Publications

Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (7) (2024)
Junhui Yang, Yunjie Zhang, Yifan Kong, Jiawei Lin, Guoqing Zhu, Hao Zhang, Zhijie Yu, Pixu Liu, Jinglin Xia
Diagnostic value of serum inflammatory markers in predicting early refractoriness of transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer Stage 0, A, and B hepatocellular carcinoma. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57 (2024)
Tuo Deng, Jungang Zhao, Yifan Tong, Ziyan Chen, Bangjie He, Jiacheng Li, Bo Chen, Rizhao Li, Liming Deng, Haitao Yu, Baofu Zhang, Tan Zhang, Zhehao Shi, Boyang Gao, Junyan Jiang, Yunfeng Shan, Zhengping Yu, Yuepeng Jin, Yi Wang, Jinglin Xia, Gang Chen
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC. Oncogene (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Tuo Deng, Jungang Zhao, Yifan Tong, Ziyan Chen, Bangjie He, Jiacheng Li, Bo Chen, Rizhao Li, Liming Deng, Haitao Yu, Baofu Zhang, Tan Zhang, Zhehao Shi, Boyang Gao, Junyan Jiang, Yunfeng Shan, Zhengping Yu, Yuepeng Jin, Yi Wang, Jinglin Xia, Gang Chen
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC. Oncogene (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (7) (2024)
Tuo Deng, Jungang Zhao, Yifan Tong, Ziyan Chen, Bangjie He, Jiacheng Li, Bo Chen, Rizhao Li, Liming Deng, Haitao Yu, Baofu Zhang, Tan Zhang, Zhehao Shi, Boyang Gao, Junyan Jiang, Yunfeng Shan, Zhengping Yu, Yuepeng Jin, Yi Wang, Jinglin Xia, Gang Chen
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC. Oncogene 43 (13) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Tuo Deng, Jungang Zhao, Yifan Tong, Ziyan Chen, Bangjie He, Jiacheng Li, Bo Chen, Rizhao Li, Liming Deng, Haitao Yu, Baofu Zhang, Tan Zhang, Zhehao Shi, Boyang Gao, Junyan Jiang, Yunfeng Shan, Zhengping Yu, Yuepeng Jin, Yi Wang, Jinglin Xia, Gang Chen
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC. Oncogene 43 (13) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Tuo Deng, Jungang Zhao, Yifan Tong, Ziyan Chen, Bangjie He, Jiacheng Li, Bo Chen, Rizhao Li, Liming Deng, Haitao Yu, Baofu Zhang, Tan Zhang, Zhehao Shi, Boyang Gao, Junyan Jiang, Yunfeng Shan, Zhengping Yu, Yuepeng Jin, Yi Wang, Jinglin Xia, Gang Chen
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC. Oncogene 43 (13) (2024)
Jie Li, Song Yang, Yaling Li, Chengjun Li, Yuhan Xia, Shishi Zhu, Jinglin Xia
The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study. Cardiovascular and interventional radiology 45 (9) (2022)
Chengshui Chen, Feng Qi, Keqing Shi, Yuping Li, Ji Li, Yongping Chen, Jingye Pan, Tieli Zhou, Xiangyang Lin, Jinsan Zhang, Yongde Luo, Xiaokun Li, Jinglin Xia
Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019. Clinical and translational medicine 10 (2) (2020)